Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease

Gene

Volumn 496, Issue 1, 2012, Pages 63-67

  Gupta, Abhishak Chandra ^a,c,d   Misra, Richa ^b   Sakhuja, Puja ^b   Singh, Yogendra ^b   Basir, Seemi Farhat ^d   Sarin, Shiv Kumar ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b G B PANT HOSPITAL   (India)

^c CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^d JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Adiponectin; Hypoadiponectemia; Nonalcoholic fatty liver disease; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; EXONS; FATTY LIVER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863394339     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.023     Document Type: Article

References (34)

1. Adams L.A., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
2. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346:1221-1231.
3. Angulo P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356-1362.
4. Brunt E.M. Histopathology of non-alcoholic fatty liver disease. Clin. Liver Dis. 2009, 13:533-544.
5. Butte N.F., et al. Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children. J. Clin. Endocrinol. Metab. 2005, 90:4170-4176.
6. Chitturi S., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
7. Chitturi S., Farrell G.C., George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?. J. Gastroenterol. Hepatol. 2004, 19:368-374.
8. Clark J.M., Diehl A.M. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003, 289:3000-3004.
9. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 2002, 122:1649-1657.
10. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.
11. Gu H.F., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 2004, 53:S31-S35.
12. Heid I.M., et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55:375-384.
13. Hoffstedt J., et al. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J. Clin. Endocrinol. Metab. 2004, 89:1391-1396.
14. Hotta K., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
15. Kang E.S., et al. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care 2005, 28:1139-1144.
16. Kleiner D.E., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
17. Laumen H., et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009, 58:984-991.
18. Li Z., et al. The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes. Diabetes Obes. Metab. 2008, 10:794-802.
19. Louthan M.V., et al. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J. Pediatr. 2005, 147:835-838.
20. Musso G., et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 2008, 47:1167-1177.
21. Namvaran F., et al. Distribution and genotype frequency of adiponectin (+45 T/G) and adiponectin receptor2 (+795 G/A) single nucleotide polymorphisms in Iranian population. Gene 2011, 486:97-103.
22. Pagano G., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-372.
23. Pajvani U.B., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 2003, 278:9073-9085.
24. Pantsulaia I., et al. Relationship between obesity, adipocytokines, and blood pressure: possible common genetic and environmental factors. Am. J. Hum. Biol. 2009, 21:84-90.
25. Qi L., et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 2006, 55:1512-1516.
26. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002, 123:1705-1725.
27. Tokushige K., et al. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J. Gastroenterol. 2009, 44:976-982.
28. Tsuzaki K., et al. Adiponectin gene single-nucleotide polymorphisms and treatment response to obesity. J. Endocrinol. Invest. 2009, 32:395-400.
29. Vionnet N., et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 2000, 67:1470-1480.
30. Virsaladze D., et al. Plasma adipocytokine levels in obese and insulin resistant postmenopausal females with type 2 diabetes. Georgian Med. News 2007, 142:25-28.
31. Weyer C., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.
32. Wolf G. Adiponectin: a regulator of energy homeostasis. Nutr. Rev. 2003, 61:290-292.
33. Wong V.W., et al. Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J. Gastroenterol. Hepatol. 2008, 23:914-921.
34. Yamauchi T., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 2003, 278:2461-2468.